As specified in regulations at 419.66(b)(1) through (3), to be eligible for transitional pass-through payment under the OPPS, a device must meet the following criteria: If required by FDA, the device must have received FDA approval or clearance and FDA marketing authorization (except for a device that has received an FDA investigational device exemption (IDE) and has been classified as a Category B device by FDA), or meet another appropriate FDA exemption
While waiting, wash your hands again and prepare your workspace
This includes some heartburn medicines including proton pump inhibitors (PPIs) such as rabeprazole, omeprazole, esomeprazole, lansoprazole and pantoprazole
This includes: Product release decisions Sterility assurance Environmental monitoring Laboratory testing Stability programs Batch disposition Once confidence in data is lost, FDA must assume that the entire quality system may be compromised
Enter your email address: Your privacy is important to us
Appending correct J-Codes in billing forms promises correct reimbursement against administering non-oral drugs